or Try an Advanced Search...

    Technical Analysis for PTPI - Petros Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 0.62 -2.43% -0.02
    PTPI closed down 6.72 percent on Wednesday, April 24, 2024, on 21 percent of normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical PTPI trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing Low Bearish -2.43%
    New 52 Week Low Weakness -2.43%
    Wide Bands Range Expansion -2.43%
    Oversold Stochastic Weakness -2.43%
    Wide Bands Range Expansion -8.98%
    Gapped Up Strength -8.98%
    Oversold Stochastic Weakness -8.98%
    New 52 Week Closing Low Bearish -4.80%
    Narrow Range Bar Range Contraction -4.80%
    New 52 Week Low Weakness -4.80%
    Older End-of-Day Signals for PTPI ...

       Recent Intraday Alerts

    Alert Time
    Down 5% about 1 hour ago
    Down 3% about 1 hour ago
    Fell Below Previous Day's Low about 1 hour ago
    Down 2 % about 1 hour ago
    Down 1% about 1 hour ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    PTPI Chart by TradingView
    Basic chart:

    Profile

    Petros is committed to becoming the world's leading men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, but not limited to ED, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease (acute and chronic), hormone health and substance use disorders.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Disease Disorders Dysfunction Chronic Condition Petros Men's Health Psychosocial Substance Use Disorder

    Is PTPI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 16 Petros Pharmaceuticals Receives Positive Response from FDA Following Recent Demonstration of Technology Component in Pursuit of OTC Status for STENDRA(R) (avanafil)
    Apr 2 Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Apr 2 Petros Pharmaceuticals Reports Positive Results in an Initial Cohort Two-Arm Self-Selection (Phase 2-Equivalent) Study for STENDRA(R) (avanafil) as it Pursues OTC Status
    Mar 19 Petros Pharmaceuticals Successfully Launches AI Tool In Collaboration with Multi-Billion-Dollar Software Provider
    Feb 14 Petros Pharmaceuticals Enters into AI Licensing Agreement with Leading Multi-Billion-Dollar Software Provider
    Jan 24 Petros Pharmaceuticals Announces Two Upcoming FDA Meetings to Review Progress and Path Forward for STENDRA(R) (avanafil) Rx-to-OTC Switch
    Jan 17 Petros Pharmaceuticals Demonstrates Positive Results Following Successful Completion of Initial Cohort of Phase 2 Equivalent Self-Selection Study for STENDRA (avanafil) Rx-to-OTC Switch
    Dec 13 Why ReShape Lifesciences Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
    Dec 12 Petros Pharmaceuticals Successfully Completes Important Study in Effort to Make STENDRA(R) (avanafil) the First Erectile Dysfunction Medication to Achieve OTC Status
    Dec 12 Petros Pharmaceuticals Partners with Blockbuster Cholesterol Drug(1) Crestor’s (rosuvastatin) OTC Switch Technology Provider
    See more PTPI news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.2399
    52 Week Low 0.62
    Average Volume 888,312
    200-Day Moving Average 1.77
    50-Day Moving Average 1.30
    20-Day Moving Average 0.91
    10-Day Moving Average 0.73
    Average True Range 0.11
    RSI (14) 23.66
    ADX 33.55
    +DI 14.31
    -DI 28.10
    Chandelier Exit (Long, 3 ATRs) 1.26
    Chandelier Exit (Short, 3 ATRs) 0.95
    Upper Bollinger Bands 1.42
    Lower Bollinger Band 0.40
    Percent B (%b) 0.23
    BandWidth 111.98
    MACD Line -0.19
    MACD Signal Line -0.18
    MACD Histogram -0.0116
    Fundamentals Value
    Market Cap 1.4 Million
    Num Shares 2.2 Million
    EPS -6.21
    Price-to-Earnings (P/E) Ratio -0.10
    Price-to-Sales 0.44
    Price-to-Book 0.37
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.74
    Resistance 3 (R3) 0.75 0.72 0.72
    Resistance 2 (R2) 0.72 0.69 0.71 0.72
    Resistance 1 (R1) 0.68 0.67 0.66 0.67 0.71
    Pivot Point 0.65 0.65 0.64 0.64 0.65
    Support 1 (S1) 0.61 0.62 0.59 0.60 0.56
    Support 2 (S2) 0.58 0.60 0.57 0.55
    Support 3 (S3) 0.54 0.58 0.55
    Support 4 (S4) 0.53